Insider Selling: Accuray Incorporated (NASDAQ:ARAY) CFO Sells 8,404 Shares of Stock

Accuray Incorporated (NASDAQ:ARAY) CFO Ali Pervaiz sold 8,404 shares of the stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $2.06, for a total transaction of $17,312.24. Following the transaction, the chief financial officer now directly owns 394,138 shares of the company’s stock, valued at $811,924.28. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Accuray Stock Performance

Accuray stock traded down $0.07 during trading on Friday, hitting $1.92. The stock had a trading volume of 623,696 shares, compared to its average volume of 670,268. The company has a quick ratio of 0.78, a current ratio of 1.58 and a debt-to-equity ratio of 4.05. The stock’s 50 day moving average is $1.90 and its two-hundred day moving average is $2.05. Accuray Incorporated has a 1 year low of $1.40 and a 1 year high of $3.10. The stock has a market cap of $190.55 million, a price-to-earnings ratio of -8.91 and a beta of 1.45.

Accuray (NASDAQ:ARAY) last posted its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported $0.03 earnings per share for the quarter, hitting the consensus estimate of $0.03. Accuray had a negative return on equity of 33.39% and a negative net margin of 3.48%. The company had revenue of $134.29 million during the quarter, compared to the consensus estimate of $122.80 million. During the same quarter in the prior year, the company earned ($0.03) EPS. As a group, analysts predict that Accuray Incorporated will post -0.01 EPS for the current year.

Institutional Trading of Accuray

A number of institutional investors have recently modified their holdings of the business. Nisa Investment Advisors LLC grew its holdings in Accuray by 253,483.3% in the 2nd quarter. Nisa Investment Advisors LLC now owns 15,215 shares of the medical equipment provider’s stock worth $28,000 after acquiring an additional 15,209 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Accuray during the fourth quarter valued at approximately $29,000. AQR Capital Management LLC bought a new stake in Accuray in the 2nd quarter worth approximately $30,000. Victory Capital Management Inc. purchased a new stake in Accuray during the 4th quarter valued at $35,000. Finally, Simplicity Wealth LLC purchased a new position in shares of Accuray in the 1st quarter worth $49,000. 64.08% of the stock is currently owned by hedge funds and other institutional investors.

About Accuray

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate.